Susquehanna Fundamental Investments, LLC Ocuphire Pharma, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.82 - $2.79 $19,929 - $30,550	-10,950 Reduced 42.03%	15,105 $30,000
Q1 2022 May 16, 2022	SELL	$2.75 - $4.39 $525 - $838	-191 Reduced 0.73%	26,055 $84,000
Q4 2021 Feb 14, 2022	BUY	$3.4 - $5.19 $24,497 - $37,393	7,205 Added 37.84%	26,246 $98,000
Q3 2021 Nov 15, 2021	BUY	$3.84 - $5.38 $9,984 - $13,988	2,600 Added 15.81%	19,041 $98,000
Q2 2021 Aug 11, 2021	BUY	$4.24 - $6.57 $69,709 - $108,017	16,441 New	16,441 $87,000

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.